Filter Results:
(231)
Show Results For
- All HBS Web
(231)
- News (35)
- Research (170)
- Events (7)
- Multimedia (3)
- Faculty Publications (95)
Show Results For
- All HBS Web
(231)
- News (35)
- Research (170)
- Events (7)
- Multimedia (3)
- Faculty Publications (95)
- May 15, 2012
- Article
Ensuring Quality Cancer Care: A Follow-Up Review of the Institute of Medicine’s 10 Recommendations for Improving the Quality of Cancer Care in America
By: Tracy E. Spinks, Heidi W. Albright, Thomas W. Feeley, Ron Walters, Thomas W. Burke, Thomas Aloia, Eduardo Bruera, Aman Buzdar, Lewis Foxhall, David Hui, Barbara Summers, Alma Rodriguez, Raymond DuBois and Kenneth I. Shine
Responding to growing concerns regarding the safety, quality, and efficacy of cancer care in the United States, the Institute of Medicine (IOM) of the National Academy of Sciences commissioned a comprehensive review of cancer care delivery in the US health care system... View Details
Keywords: Cancer; Quality; Cancer Care In The U.S.; Quality Improvement; Health Care and Treatment; Health Industry; North and Central America
Spinks, Tracy E., Heidi W. Albright, Thomas W. Feeley, Ron Walters, Thomas W. Burke, Thomas Aloia, Eduardo Bruera, Aman Buzdar, Lewis Foxhall, David Hui, Barbara Summers, Alma Rodriguez, Raymond DuBois, and Kenneth I. Shine. "Ensuring Quality Cancer Care: A Follow-Up Review of the Institute of Medicine’s 10 Recommendations for Improving the Quality of Cancer Care in America." Cancer 118, no. 10 (May 15, 2012): 2571–2582.
- January–February 2023
- Article
Data-Driven COVID-19 Vaccine Development for Janssen
By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Bertsimas, Dimitris, Michael Lingzhi Li, Xinggang Liu, Jennings Xu, and Najat Khan. "Data-Driven COVID-19 Vaccine Development for Janssen." INFORMS Journal on Applied Analytics 53, no. 1 (January–February 2023): 70–84.
- 09 May 2013
- Working Paper Summaries
Clusters of Entrepreneurship and Innovation
- May 2024
- Article
Design of Off-Grid Lighting Business Models to Serve the Poor: Field Experiments and Structural Analysis
By: Bhavani Shanker Uppari, Serguei Netessine, Ioanna Popescu and Rowan P. Clarke
A significant proportion of the world's population has no access to grid-based electricity and so relies on off-grid lighting solutions. Rechargeable lamp technology is gaining popularity as an alternative off-grid lighting model in developing countries. In this paper,... View Details
Keywords: Technological Innovation; Developing Countries and Economies; Consumer Behavior; Poverty; Logistics; Business Model; Utilities Industry
Uppari, Bhavani Shanker, Serguei Netessine, Ioanna Popescu, and Rowan P. Clarke. "Design of Off-Grid Lighting Business Models to Serve the Poor: Field Experiments and Structural Analysis." Management Science 70, no. 5 (May 2024): 3038–3058.
- 25 Jul 2017
- First Look
First Look at New Research and Ideas: July 25, 2017
forthcoming Journal of Political Economy Reserve Design: Unintended Consequences and the Demise of Boston's Walk Zones By: Dur, Umut, Scott Duke Kominers, Parag A. Pathak, and Tayfun Sönmez Abstract—Admissions policies often use reserves to grant certain applicants... View Details
Keywords: Carmen Nobel
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 29 Jan 2019
- HBS Seminar
Bryan Bollinger, Fuqua School of Business at Duke University
- Web
Impact Investments
return profiles are realistic? How are impact investments structured to maximize efficacy and how can the dual goals of building both financial and social value through investments most effectively be achieved? The Project on Impact... View Details
- 10 Oct 2023
- Research & Ideas
In Empowering Black Voters, Did a Landmark Law Stir White Angst?
rise in Black political efficacy that the [law] intended to achieve,” the researchers write Long shadow lingers today The findings have implications for the upcoming fall elections, and interpretation of the federal laws under recent... View Details
Keywords: by Rachel Layne
- Web
Asia Pacific - Global
HBS Club of Singapore, respectively. During the talk, he explained the sources of misinformation that investors faced in capital markets, discussed the origins of conflicts of interest, and analyzed the efficacy of new intermediaries,... View Details
- Person Page
Press / Media
By: Gary P. Pisano
Thought Leader: Gary Pisano
by Amy Bernstein, strategy+business, Summer 2007
A leading student of the biotech business describes the problems holding the industry back, and how it can overcome... View Details
- 03 Jan 2013
- Working Paper Summaries
The Value of Advice: Evidence from Mobile Phone-Based Agricultural Extension
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- 25 Jan 2016
- Research & Ideas
When Negotiating a Price, Never Bid with a Round Number
public US-based companies between 1985 and 2012, looking at the price-per-share number of each offer. Based on what they already knew about the efficacy of precise numbers, they assumed that round-number bids would be in the minority. But... View Details
Keywords: by Carmen Nobel
- 12 Apr 2022
- Research & Ideas
Swiping Right: How Data Helped This Online Dating Site Make More Matches
some estimates, with players such as Bumble, Tinder, and OKCupid vying to help people find love. While McFowland is not a dating expert, his work in machine learning and social sciences examines the efficacy of how people interact in... View Details
Keywords: by Kara Baskin
- Web
Technology & Innovation - Faculty & Research
driver of wealth creation and economic growth. Partnerships to foster the translational processes from public research organizations, such as universities and hospitals, to private firms are a policy tool that has attracted increased interest. Yet questions about the... View Details
- 27 Aug 2013
- Working Paper Summaries
The Impact of Patent Wars on Firm Strategy: Evidence from the Global Smartphone Market
- 30 Nov 2015
- Research & Ideas
Donors Are Turned Off by Overhead Costs. Here’s What Charities Can Do
would be covered by someone else. AN OVERHEAD-FREE OPTION PAYS OFF IN THE REAL WORLD Continuing to pursue the efficacy of a dedicated overhead benefactor, Keenan and her colleagues took their research to the real world, conducting a field... View Details
Keywords: by Carmen Nobel
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
collected to support the safety and efficacy of new drugs is vital to supporting the FDA’s mandate to protect public health,” Stern says. “But at the same time, if there are ways to accelerate the development of new medicines without... View Details
- 13 Aug 2012
- Research & Ideas
When Good Incentives Lead to Bad Decisions
experimental field study, the researchers set out to test the efficacy of three distinct incentive schemes for employees in charge of assessing risk and issuing loans: the origination bonus (in which officers are rewarded a commission for... View Details